Loss of Cell Differentiation in HPV-Associated Bladder Cancer


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Medical histories of 101 urothelial bladder cancer patients were compared with the results of morphological analysis and biomolecular detection of human papilloma viruses (HPV) in the tumor specimens. DNA of HPV16 (the major type of virus responsible for appearance of cervical carcinoma) was detected in 38 specimens, while mRNA of E6 and E7 oncogenes and E7 oncoprotein of HPV16 were observed in 13 specimens. HPV-positive bladder cancer was characterized by higher degree of cell anaplasia than HPV-negative cancer; in the primary bladder tumor, HPV was detected more often than in recurrent bladder cancer. These data attest to involvement of HPV16 in the genesis of bladder cancer. No correlations of HPV status of bladder tumor with patient’s sex, age, and invasion into the muscle layer were revealed.

About the authors

D. A. Golovina

N. N. Blokhin Russian Cancer Research Center

Email: galina.volgareva@yandex.ru
Russian Federation, Moscow

V. D. Ermilova

N. N. Blokhin Russian Cancer Research Center

Email: galina.volgareva@yandex.ru
Russian Federation, Moscow

L. E. Zavalishina

Department of Pathological Anatomy, Russian Medical Academy for Post-Graduate Education, Ministry of Health of the Russian Federation

Email: galina.volgareva@yandex.ru
Russian Federation, Moscow

Yu. Yu. Andreeva

Department of Pathological Anatomy, Russian Medical Academy for Post-Graduate Education, Ministry of Health of the Russian Federation

Email: galina.volgareva@yandex.ru
Russian Federation, Moscow

V. B. Matveev

N. N. Blokhin Russian Cancer Research Center

Email: galina.volgareva@yandex.ru
Russian Federation, Moscow

G. A. Frank

Department of Pathological Anatomy, Russian Medical Academy for Post-Graduate Education, Ministry of Health of the Russian Federation

Email: galina.volgareva@yandex.ru
Russian Federation, Moscow

G. M. Volgareva

N. N. Blokhin Russian Cancer Research Center

Author for correspondence.
Email: galina.volgareva@yandex.ru
Russian Federation, Moscow


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies